Shenzhen Chipscreen Biosciences Co., Ltd.
688321.SS
Get informed when a big investor buys or sells
+ FollowMarket Cap$10.77B
Close$
Share Statistics
| Market cap | $10.77 Billion |
|---|---|
| Enterprise Value | $11.60 Billion |
| Dividend Yield | $0.06 (0.24%) |
| Earnings per Share | $0.13 |
| Beta | 0.66 |
| Outstanding Shares | 440,862,874 |
Return
| Return on Equity | 3.64% |
|---|---|
| Return on Assets | 2.01% |
| Return on Invested Capital | 3.70% |
Valuation & Multiples
| P/E Ratio | 112.55 |
|---|---|
| PEG | -973.06 |
| Price to Sales | 10.98 |
| Price to Book Ratio | 4.39 |
| Enterprise Value to Revenue | 11.08 |
| Enterprise Value to EBIT | 82.48 |
| Enterprise Value to Net Income | 125 |
| Total Debt to Enterprise | 0.13 |
| Debt to Equity | 0.59 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 19, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Shenzhen Chipscreen Biosciences Co., Ltd.
1,031 employees
CEO: Xian-Ping Lu Established in 2001 and headquartered in Shenzhen, China, Chipscreen Biosciences specializes in the discovery, development, and commercialization of innovative small-molecule pharmaceuticals. The company cultivates a pipeline of novel dr...